MUCOSOLVAN 15 MG/5 ML SYRUP 200 ML BOTTLE WILD BERRY FLAVOR

Name
MUCOSOLVAN 15 mg/5 ml wild berry-flavored syrup
Ambroxol


What is it and what is it used for?
Mucosolvan contains ambroxol, an active ingredient that works by loosening phlegm and facilitating its elimination. Mucosolvan is used in adults and children over 2 years of age to treat secretions in acute and chronic bronchial and lung diseases (i.e., in the presence of a cough and difficulty clearing phlegm from the bronchi due to increased or thickened phlegm).


What you need to know before taking the medicine
Talk to your doctor or pharmacist before using Mucosolvan:
- if you/your child has/has had lesions of the stomach and/or intestine (peptic ulcer).

Cases of serious skin reactions associated with ambroxol administration have been reported. If you experience a skin rash (including lesions of the mucous membranes such as the mouth, throat, nose, eyes, and genitals), stop taking Mucosolvan and contact your doctor immediately.
These reactions could be symptoms of serious skin conditions characterized by peeling skin and severe toxic skin reaction (Stevens-Johnson syndrome and Toxic Epidermal Necrolysis).

Additionally, in the early stages of Stevens-Johnson syndrome or Toxic Epidermal Necrolysis (TEN), you/your child may experience nonspecific flu-like symptoms, such as fever, chills, runny nose (rhinitis), cough, and sore throat. Because of these misleading symptoms, you may be re-initiated on symptomatic treatment with cough and cold medication.

Children
Do not give this medicine to children under 2 years of age. Mucolytics can cause bronchial obstruction in children under 2 years of age. Indeed, the ability to drain bronchial mucus is limited in this age group due to the physiological characteristics of the airways.


Warnings and precautions
Tell your doctor or pharmacist if you/your child are taking, have recently taken, or might take any other medicines. In particular, following the administration of ambroxol, the concentrations of antibiotics (amoxicillin, cefuroxime, erythromycin) in bronchopulmonary secretions and saliva are increased.


Possible side effects
December 2022